Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 18 Breast Neoplasms 15 Pancreatic Neoplasms 13 Colorectal Neoplasms 10 Rectal Neoplasms 7 Stomach Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Neoplasms 5 Recurrence 4 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Lymphoma, T-Cell, Peripheral 3 Leukemia, Myeloid, Acute 3 Esophageal Squamous Cell Carcinoma 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Treatment 2 Solid Tumor 2 Small Cell Lung Cancer Limited Stage 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Esophageal Neoplasms 2

Interventions

Radiotherapy, Intensity-Modulated 2 Magnetic Resonance Spectroscopy 2 regorafenib 1 delta 24-sterol reductase 1 Vinorelbine 1 Standard of Care 1 Specimen Handling 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Proton Therapy 1 Physical Therapy Modalities 1 Liquid Biopsy 1 IVA protocol 1 Electroacupuncture 1 Drug Therapy 1 Doxorubicin 1 Cyclophosphamide 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Sarcoma, Ewing × Drug Therapy × Clear all

NCT07188532 2026-05-11

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡